Document is current

Article History

Received: 22 February 2023

Accepted: 1 September 2023

First Online: 18 September 2023

Declarations

:

: Consent to participate in this qualitative analysis was obtained prior to the initiation of the interview and was read from a pre-approved script to ensure standardization across the consent process. Further, participants were given the opportunity to end the interview and/or refuse to answer any question they did not feel comfortable answering. The Johns Hopkins University and Maryland Department of Health institutional review boards both individually approved the study (IRB 17601).

: Consent for participation in this study was obtained prior to interviews. Data was anonymized and kept on a secure, password protected server, to ensure protection of the individual’s responses.

: Craig Pollack received grants from the National Institutes of Health. He reports stock ownership in Gilead Pharmaceuticals. From September 2019 to July 2022, Johns Hopkins University entered a contract with the Department of Housing and Urban Development (HUD) for Pollack to work part-time on a temporary assignment, assisting the department on housing and health issues.